Molecular Data - ADR Financials

$0.00

$0.00 (10.00%)

As on 08-Nov-2022 09:30EDT

Market cap

$5 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Income Statement (CN¥ Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Operating Revenue	--	7,596.41	13,207.32	9,053.27	4,201.91	3,206.08
Cost of Revenue	--	7,606.61	13,106.54	8,973.10	4,151.67	3,179.96
Gross Profit	--	-10.20	100.77	80.17	50.23	26.12
Operating Expenses	--	321.36	292.99	315.96	139.97	131.89
Operating Profit (EBIT)	--	-331.56	-192.21	-235.79	-91.18	-105.77
Other Income	--	--	--	--	--	--
Profit before Tax	--	-325.58	-193.08	-254.64	-107.81	-113.94
Provision for Tax	1.49	2.46	0.47	--	--	--
Profit after Tax (Net Income)	--	-328.04	-193.55	-254.64	-107.81	-113.94
Minority Interest	0.86	0.09	0.09	0.09	0.09	--
Consolidated Profit	-255.83	-328.00	-193.55	-254.64	-107.81	-113.94

Liabilities (CN¥ Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Shareholder's Funds	64.31	-27.93	-216.50	-61.63	5.90	--
Minority Interest	0.86	--	--	--	--	--
Non-Current Liabilities	18.80	20.09	33.45	177.81	75.39	--
Current Liabilities	662.66	692.61	675.76	255.42	299.86	--
Total Liabilities	1,408.42	684.82	492.72	371.60	381.15	--

Assets (CN¥ Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Non-Current Assets	15.16	21.64	5.89	3.90	4.69	--
Current Assets	730.93	663.19	486.83	367.70	376.46	--
Total Assets	1,408.75	684.77	492.72	371.60	381.15	--
Total Debt*	75.45	71.09	50.28	177.86	213.57	--
Net Current Assets	68.27	-29.42	-188.93	112.29	76.60	--

Cashflow (CN¥ Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Cash From Operating Activities	--	-234.05	-95.82	-134.64	-186.70	-145.59
Cash Flow from Investing Activities	--	-320.31	-1.82	-2.24	-3.98	-2.65
Cash from Financing Activities	--	529.14	149.40	37.33	262.85	173.30
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Adjusted EPS (CN¥)	--	-0.84	-1.87	-0.74	--	--
Cash EPS (CN¥)	--	-0.84	-1.84	-0.73	--	--
Adjusted Book Value (CN¥)	--	--	--	--	--	--
Dividend per Share (CN¥)	--	--	--	--	--	--
Cash Flow per Share (CN¥)	--	-0.60	-0.93	-0.39	--	--
Free Cash Flow per Share (CN¥)	--	-0.60	-0.94	-0.40	--	--

Profitability Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
ROCE (%)	--	533.17	774.47	-151.70	-98.24	--
ROE (%)	--	268.42	139.18	913.93	-1,826.93	--
ROA (%)	--	-55.72	-44.79	-67.66	-28.28	--
EBIT Margin (%)	--	-4.14	-1.43	-2.60	-2.17	-3.29
Net Margin (%)	--	-4.32	-1.47	-2.81	-2.57	-3.55
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Revenue Growth (%)	--	-0.42	0.46	1.15	0.31	--
EBIT Growth (%)	-39.35	-66.84	19.90	-158.95	13.76	--
Net Profit Growth (%)	--	-69.49	23.99	-136.20	5.38	--
EPS Growth (%)	--	0.55	-1.53	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debt to Equity	--	-2.55	-0.23	-2.89	36.19	--
Short term debt to equity ratio	0.89	-1.84	-0.08	0.00	23.48	--
Current Ratio	1.10	0.96	0.72	1.44	1.26	--
Quick Ratio	1.09	0.95	0.71	1.41	1.19	--
Interest Coverage	--	-29.35	-43.21	-12.37	-5.41	-12.51

Operating Efficiency Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debtors to sales (%)	--	1.21	1.60	0.69	2.41	--
Asset Turnover	--	12.90	30.56	24.05	11.02	--
Receivable days	--	7.29	3.78	3.30	8.80	--
Inventory Days	--	0.17	0.16	0.54	1.69	--
Payable days	--	14.89	4.93	2.37	5.90	--
Cash Conversion Cycle	--	-7.43	-0.99	1.47	4.59	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.